A comprehensive view of Merck KGaA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novo Nordisk, Lilly, Sanofi, Merck KGaA partner to recycle 25% of the 6 million insulin pens they sell in Denmark; the initiative aims to reclaim around 25 tons of plastic from the pens; 60% of which is high-quality plastic
Published: April 26, 2023 by M-Brain Nordic News
Merck KGaA regains worldwide rights to cancer immunotherapy Bavencio, ending collaboration with Pfizer; 15% royalty on net sales to be paid to Pfizer.
Published: March 28, 2023 by SeeNews Pharmaceuticals
Merck KGaA, Darmstadt, Germany and Intel Accelerate Sustainable Semiconductor Processes and Manufacturing Technologies Through Academic Research in Europe
Published: March 09, 2023 by Contify Life Science News
Merck KGaA hands over IL-12-targeting cancer drug to PDS Biotech in deal worth over US$120.0M; the two companies are currently developing a triple combination immunotherapy to treat HPV-associated malignancies
Published: January 04, 2023 by FierceBiotech
Amgen, Merck KGaA sign separate deals to develop cancer-targeting antibody-drug conjugates with external drug developers in deals worth up to US$2.0B; Amgen partners with LegoChem Biosciences, Merck partners with Mersana Therapeutics
Published: December 28, 2022 by FierceBiotech

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count